Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.

Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.

It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...

U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

By Siddhi Mahatole and Sriparna Roy (Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...